MYNZ – mainz biomed n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
Mainz Biomed B.V. GAAP EPS of -$0.49, revenue of $520.77M [Seeking Alpha]
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
Form 6-K MAINZ BIOMED N.V. For: Nov 15
Form 6-K MAINZ BIOMED N.V. For: Nov 12
Form F-1 MAINZ BIOMED N.V.
Form 6-K MAINZ BIOMED N.V. For: Oct 21
Form 6-K MAINZ BIOMED N.V. For: Jun 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.